Nanohale AG (ETR:FYB) | Finanzwire

Basculer en Français

9478	Companies
185484	Keywords
117839	Articles
99329	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 06/25/2025 at 06:35, 5 months 10 days ago

Valorum Biologics Partners with Formycon for FYB203 in North America

Partnership Biosimilars Commercialization Ophthalmology North America Market
PRESS RELEASE

published on 06/25/2025 at 06:30, 5 months 10 days ago

U.S. biosimilar specialist Valorum Biologics LLC becomes commercialization partner for Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® (aflibercept-mrbb) in the United States and Canada
Valorum Biologics LLC partners with Formycon AG for commercialization of Eylea biosimilar FYB203/AHZANTIVE in the United States and Canada. Major shareholder ATHOS KG supports financing

Formycon AG Eylea Biosimilar Valorum Biologics Commercialization Partner ATHOS KG
BRIEF

published on 06/24/2025 at 19:55, 5 months 10 days ago

Strong Demand Leads to Early Closing of Formycon Bond Subscription

Frankfurt Stock Exchange Institutional Investors Formycon AG Financial Flexibility Bond Subscription
PRESS RELEASE

published on 06/24/2025 at 19:50, 5 months 10 days ago

Strong demand for Formycon 2025/2029 Bond leads to early closing of subscription period
Formycon AG experiences high demand for its 2025/2029 Bond, leading to an early closure of the subscription period. Institutional investors show significant interest in the bond

Institutional Investors Formycon AG Financial Flexibility Subscription Period 2025/2029 Bond
BRIEF

published on 06/20/2025 at 09:05, 5 months 15 days ago

Formycon AG Launches Flexible Bond Subscription via Deutsche Börse

Formycon AG Financial Strategy Deutsche Börse Corporate Bond Biosimilar Development
PRESS RELEASE

published on 06/20/2025 at 09:00, 5 months 15 days ago

Formycon bond 2025/2029: Public subscription now also possible via Deutsche Börse
Formycon AG announces public subscription for its 2025/29 corporate bond via Deutsche Börse's DirectPlace service, offering a target volume of €50 million with a variable interest rate

Subscription Formycon AG Deutsche Börse Corporate Bond 2025/29
BRIEF

published on 06/18/2025 at 16:48, 5 months 16 days ago

Formycon AG's AGM Approves New Resolutions

Supervisory Board Formycon AG Biosimilars Financial Outlook AGM Resolutions
PRESS RELEASE

published on 06/18/2025 at 16:43, 5 months 16 days ago

Ordinary Annual General Meeting of Formycon AG approves all proposed resolutions by large majorities
Formycon AG's Ordinary Annual General Meeting approval of resolutions and expansion of Supervisory Board demonstrated strong shareholder support and strategic growth focus

Annual General Meeting Supervisory Board Formycon AG Biosimilars Resolutions
BRIEF

published on 06/18/2025 at 06:30, 5 months 17 days ago

Formycon AG Launches Subscription for New Corporate Bond

Capital Markets Interest Rates Formycon AG Corporate Bond Biosimilar Development
PRESS RELEASE

published on 06/18/2025 at 06:25, 5 months 17 days ago

Formycon AG: Subscription period for 2025/2029 corporate bond has started
Formycon AG announces the start of the subscription period for the 2025/2029 corporate bond with a target volume of EUR 50 million, featuring a variable interest rate. Investors can submit subscription offers until June 27, 2025

Growth Strategy Formycon AG Interest Rate Corporate Bond Subscription Period

Accesswire

Published on 12/05/2025 at 15:35, 15 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 25 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 50 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 50 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 50 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 15:47, 2 minutes ago

Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Published on 12/05/2025 at 15:39, 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Published on 12/05/2025 at 15:38, 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Published on 12/05/2025 at 15:36, 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Published on 12/05/2025 at 15:35, 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.

Les Echos

Published on 12/05/2025 at 15:10, 39 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 7 hours 5 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 21 hours 50 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 22 hours 5 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 22 hours 6 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution

View all LES ECHOS COMFI WIRE